CHMP Adopts Positive Opinion for BAVENCIO(R)(avelumab) Plus Ax... - 20 September 2019 23:10

DARMSTADT, Germany and NEW YORK, September 20, 2019 /PRNewswire-AsiaNet / -- Not intended for US, Canada and UK-based media - Opinion based on Phase III data showing combination lowered risk of disease progression or death by 31% and improved objective response rate compared with sunitinib [1] - Decision by the Eu...

  More Than 9 in 10 Surgeons Encounter a Needlestick Injury, New... - 20 September 2019 01:05

LONDON, Sept. 20, 2019/PRNewswire-AsiaNet/-- - 81% believe high quality gloves impact patient outcomes; - 92% agreed high quality gloves improve safety of clinicians; - Survey demonstrates importance surgeons place on high quality gloves in protecting against infection and patient safety;...

  More than 800 pharmaceutical companies from 23 countries gathe... - 19 September 2019 20:54

NANJING, China, Sept. 19, 2019 /Xinhua-AsiaNet/-- The 10th China (Taizhou) International Medical Expo, hosted by the Jiangsu Provincial People's Government and the Taizhou Municipal People's Government, is held in China Taizhou Medical City from September 18 to 20. With the support of the Min...

  Tresiba(R) Showed an Overall Lower Risk of Hypoglycaemia and S... - 19 September 2019 20:01

BARCELONA, Spain, September 19, 2019, /PRNewswire-AsiaNet/-- According to new data from the CONCLUDE head-to-head trial, Tresiba(R) (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a hypo or low blood sugar, at a significantly lower HbA1c, compared with insulin glargine U300 i...

  BookDoc, partners it's way to being Southeast Asia's Next Gene... - 19 September 2019 11:00

KUALA LUMPUR, Malaysia, Sept. 19, 2019 /PRNewswire-AsiaNet/ -- This year crosses 100 strategic partnerships in over 20 cities across Malaysia, Singapore, Indonesia, Thailand and Hong Kong. Since commenced operations in 2015, BookDoc has grown exponentially with four consecutive years of over 450% annual g...

  Rodrigo Bianchi Appointed as New LimaCorporate Advisory Board ... - 18 September 2019 22:00

SAN DANIELE DEL FRIULI, Italy, September 18, 2019, /PRNewswire-AsiaNet/-- LimaCorporate is pleased to announce that Rodrigo Bianchi will join the LimaCorporate Advisory Board. Rodrigo Bianchi is a Senior Global Executive in the Medical Device Industry with over 30 years of experience in some of the most important Ort...

  Kaspersky: Number of attacked medical devices declines globall... - 18 September 2019 08:00

MELBOURNE, Australia, Sept. 18, 2019/PRNewswire-AsiaNet/-- Human-factor remains healthcare security's biggest loophole More than two years after Wannacry ransomware crippled medical facilities and other organisations worldwide, the healthcare sector seems to be learning its lessons as Kaspersky revea...

  United Nations Political Declaration on Universal Health Cover... - 18 September 2019 04:23

GENEVA, September 18, 2019, /PRNewswire-AsiaNet/-- Oral health included in global health agenda FDI World Dental Federation (FDI) welcomes the long overdue commitment to strengthening oral health in the UN Political Declaration on Universal Health Coverage (UHC) https://www.un.org/pga/73/wp-con...

  Ozempic(R) Offers Superior Reductions in HbA1c and Body Weight... - 17 September 2019 23:53

BAGSVÆRD, Denmark, Sept. 18, 2019 /PRNewswire/ -- Novo Nordisk announced today the results from two Ozempic(R) (once-weekly semaglutide 1.0 mg) head-to-head Phase 3 clinical trials, SUSTAIN 8 and SUSTAIN 10, which showed: - Ozempic(R) was superior to treatment with the SGLT-2 inhibitor canagli...

  Oral semaglutide improves glycaemic control in people with typ... - 17 September 2019 23:09

BARCELONA, Spain, Sept. 17, 2019, /PRNewswire-AsiaNet/ -- Novo Nordisk today announced findings from an exploratory analysis of the PIONEER trial programme, showing oral semaglutide (3, 7 and 14 mg) improved glycaemic control in people with type 2 diabetes across baseline HbA1c levels. Greater reductions...